Non-response to Communication Technology Outreach for Beta-agonist Overuse in a Pragmatic Randomized Trial of Patients with Asthma 1,2 1 1 Marsha A. Raebel, PharmD , Susan M. Shetterly, MS , Glenn K. Goodrich, MS , 1 1 1 Courtney B. Anderson, MPH , Jo Ann Shoup, PhD , Nicole Wagner, MPH , and Bruce G. Bender, PhD 1 2 Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA; Division of Pediatric Behavioral Health, National Jewish Health, Denver, CO, USA. KEY WORDS: asthma; outreach; beta-agonist; response; pragmatic trial; symptoms is important, but unavailable to the ACC until after communication technology; telephone; electronic. s/he contacts the patient. The electronic outreach was designed to determine whether the patient currently had symptoms to J Gen Intern Med 33(6):809–11 DOI: 10.1007/s11606-018-4395-9 guide further contact. © Society of General Internal Medicine 2018 The study included members aged ≥ 18 diagnosed with persistent asthma and without chronic obstructive pulmonary disease. Patients were randomized 1:1 to receive a question about symptoms by text/call (call if phone was not text- INTRODUCTION enabled) or email if they overfilled from 2/9/2017 through Evidence suggests that communication
Journal of General Internal Medicine – Springer Journals
Published: Mar 12, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera